Is tumour volume an independent predictor of outcome after radical prostatectomy for high-risk prostate cancer? | Prostate Cancer and Prostatic Diseases
Prostate Cancer: Double VS triplet therapy in mHSPC - Urology Cheatsheets
Page 27 - Monitoring Prostate Cancer to Guide Treatment Decision-Making
Frontiers | Combination therapy for high-volume versus low-volume metastatic hormone-sensitive prostate cancer: A systematic review and network meta-analysis
![Definition of high and low volume, and risk in CHAARTED [54-56] and... | Download Scientific Diagram](https://www.researchgate.net/publication/344701128/figure/tbl1/AS:947382543978497@1602885008589/Definition-of-high-and-low-volume-and-risk-in-CHAARTED-54-56-and-LATITIDE-57-based.png "Definition of high and low volume, and risk in CHAARTED [54-56] and... | Download Scientific Diagram")
Definition of high and low volume, and risk in CHAARTED [54-56] and... | Download Scientific Diagram
![PDF] Oligometastatic Prostate Cancer: A Shrinking Subset or an Opportunity for Cure? | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f1e163a466a1e212478a5b9a1f84e7b254a6eba1/8-Table2-1.png "PDF] Oligometastatic Prostate Cancer: A Shrinking Subset or an Opportunity for Cure? | Semantic Scholar")
PDF] Oligometastatic Prostate Cancer: A Shrinking Subset or an Opportunity for Cure? | Semantic Scholar
Prostate Cancer: Hormonal Therapy (Androgen Ablation)
Surgical management of high-risk, localized prostate cancer | Nature Reviews Urology
Do low-grade and low-volume prostate cancers bear the hallmarks of malignancy? - ScienceDirect
Genomic profiles of de novo high- and low-volume metastatic prostate cancer: results from a 2-stage feasibility and prevalence study in the STAMPEDE Trial
Understanding the Current Therapeutic Landscape for Advanced Prostate Cancer (CME article) | Published in International Journal of Cancer Care and Delivery
APCCC 2019: Synthesis - Optimal Treatment of Men with Newly Diagnosed Prostate Cancer
September 15, 2014 - What Constitutes High-Volume/Extensive Disease? - The ASCO Post
Bone Imaging in Metastatic Castration-resistant Prostate Cancer; Where do we Stand | Bentham Science
Current Oncology | Free Full-Text | Contemporary Systemic Therapy Intensification for Prostate Cancer: A Review for General Practitioners in Oncology
Determinants of variation in radical local treatment for men with high-risk localised or locally advanced prostate cancer in England | Prostate Cancer and Prostatic Diseases
Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial - The Lancet
![Definition of high and low volume, and risk in CHAARTED [54-56] and... | Download Scientific Diagram](https://www.researchgate.net/profile/Thomas-Lam-3/publication/344701128/figure/tbl2/AS:947382543974400@1602885008617/Key-findings-hormonal-treatment-combined-with-chemotherapy-in-men-presenting-with_Q320.jpg "Definition of high and low volume, and risk in CHAARTED [54-56] and... | Download Scientific Diagram")
Definition of high and low volume, and risk in CHAARTED [54-56] and... | Download Scientific Diagram
Interdisciplinary Swiss consensus recommendations on staging and treatment of advanced prostate cancer | Swiss Medical Weekly
2023 Summaries and Changes of the undefined guideline - Uroweb
Going towards a precise definition of the therapeutic management of de-novo metastatic castration sensitive prostate cancer patients: How prognostic classification impact treatment decisions - ScienceDirect
Current Oncology | Free Full-Text | Triplet Therapy in Metastatic Castrate Sensitive Prostate Cancer (mCSPC)—A Potential New Standard of Care
Computed Tomography (CT) and Bone Scans (BS) for Hormone Sensitive Prostate Cancer
Untreated Metastatic Prostate Cancer - 2021 Prostate Cancer Patient Conference
